Literature DB >> 29317993

Transcatheter aortic valve implantation operators - get involved in imaging!

Miriam Brinkert1, Stefan Toggweiler2.   

Abstract

Pre-procedural planning is the key element of transcatheter aortic valve implantation (TAVI). Multislice computed tomography of the chest, abdomen and pelvis with the ability to perform a 3-dimensional reconstruction has become the cornerstone of pre-procedural planning. We would like to encourage TAVI operators (interventional cardiologist and surgeons) to get involved in imaging. All TAVI operators should know how to assess the annulus, the annular root, and the iliofemoral access. We strongly believe that this will improve outcomes of this evolving procedure.

Entities:  

Keywords:  Aortic stenosis; Computed tomography; Imaging; Transcatheter aortic valve implantation; Transcatheter aortic valve replacement

Year:  2017        PMID: 29317993      PMCID: PMC5746629          DOI: 10.4330/wjc.v9.i12.853

Source DB:  PubMed          Journal:  World J Cardiol


Core tip: We have noticed that only a minority of interventional cardiologists and cardiac surgeons routinely look at their patients MDCTs and know how to perform a three dimensional multiplanar reconstruction. With this editorial, we would like to encourage all transcatheter aortic valve implantation (TAVI) operators to get involved in cardiac imaging. We do believe that this will improve outcomes. In case a complication occurs, TAVI operators will be more likely to understand the nature of the complication and learn from it. And this again will lead to improved outcomes in future.

TO THE EDITOR

Transcatheter aortic valve implantation (TAVI) is now routinely performed in inoperable, high-risk, and intermediate risk patients with low mortality- and complication rates[1,2]. Some of the key elements contributing to these impressive results are pre-procedural patient evaluation by the multidisciplinary HeartTeam, and pre-procedural imaging[3,4]. The important role of multislice computed tomography (MSCT). MSCT of the chest, abdomen and pelvis with 3-dimensional reconstruction has become the cornerstone of pre-procedural planning. MSCT is now routinely performed to assess the aortic annulus, the distance between the aortic annulus and the coronary ostia and the suitability for the transfemoral access[3,5]. Nowadays matured post-processing imaging software is widely available to perform these measurements automatically and create standardized reports[6]. However, automatic measurements may not include the degree and distribution of calcification and may not take into account all aspects of the anatomy. Most of the TAVI operators rely on such reports or on numbers and measurements reported by the radiologist[7-9]. Therefore, we would like to encourage all TAVI operators to get involved in imaging and learn how to perform a 3-dimensional multiplanar reconstruction. Choosing the valve type and size. It has been shown that left ventricular outflow tract (LVOT) calcification is associated with an increased risk for annular rupture during TAVI with balloon-expandable prostheses[10]. Extensive calcifications at the native aortic valve may increase the risk for paravalvular regurgitation or need for a permanent pacemaker[11,12]. As an interventional cardiologist or cardiac surgeon, we can easily perform multiplanar reconstructions of the aortic annulus not only to measure the dimensions of the annulus but also to get an impression of the distribution of calcification of the valve leaflets and the LVOT (Figure 1)[13]. Based on all information including the annular perimeter, area, distribution of calcification and anatomy of the aortic root, valve type and size can be chosen more specifically as part of a patient tailored therapy (Figure 2).
Figure 1

Example of a multiplanar reconstruction of the aortic annulus. A and B: Double-oblique MSCT images at the basal insertion of the calcified native cusps; C: Double-oblique reconstruction at the level of the aortic annulus. The aortic valve leaflets are just barely visible at the level of the ventriculoarterial junction; D: Measurement of the short and long diameter at the level of the aortic annulus. MSCT: Multislice computed tomography.

Figure 2

Cardiac multislice computed tomography showing a patient with heavy calcifications extending into the left ventricular outflow tract and a shallow sinus. This anatomy is associated with increased risk for annular rupture in patients undergoing TAVI with a balloon expandable valve. A: Three chamber view of the heart showing a patient with heavy calcification extending from the aortic annulus into the LVOT and a shallow sinus; B: Short axis view of the aortic valve showing heavy calcified aortic leaflets. LVOT: Left ventricular outflow tract; TAVI: Transcatheter aortic valve implantation.

Example of a multiplanar reconstruction of the aortic annulus. A and B: Double-oblique MSCT images at the basal insertion of the calcified native cusps; C: Double-oblique reconstruction at the level of the aortic annulus. The aortic valve leaflets are just barely visible at the level of the ventriculoarterial junction; D: Measurement of the short and long diameter at the level of the aortic annulus. MSCT: Multislice computed tomography. Cardiac multislice computed tomography showing a patient with heavy calcifications extending into the left ventricular outflow tract and a shallow sinus. This anatomy is associated with increased risk for annular rupture in patients undergoing TAVI with a balloon expandable valve. A: Three chamber view of the heart showing a patient with heavy calcification extending from the aortic annulus into the LVOT and a shallow sinus; B: Short axis view of the aortic valve showing heavy calcified aortic leaflets. LVOT: Left ventricular outflow tract; TAVI: Transcatheter aortic valve implantation. Assessment of the coronary artery height. The “Instructions for use” of different valves include specific recommendations for the minimal coronary artery height. However, the risk for coronary obstruction is greatly increased in patients with bulky atheroma or calcifications at the tip of the leaflets, a smaller sinus of valsalva diameter, narrow sinotubular junction and different patient characteristics like female gender or patients with previous surgical bioprosthesis[14]. Measuring the coronary artery height with MSCT is a great screening tool, but ‘”virtual implantation” by the operator comparing the length of the leaflets with the distance between annulus and coronary ostia and also assessing the distribution of calcifications may allow much better risk stratification (Figure 3). Radial strength depends largely on the valve type. Whereas the widely used balloon-expandable valves consist of cobalt chromium, self-expanding valves are composed of nitinol thus applying less radial force to the tissue[14]. Accordingly, a self-expandable and retrievable valve might be preferable in patients at risk for coronary obstruction. Moreover, in case of borderline anatomy, balloonvalvuloplasty with simultaneous contrast media injection may allow to estimate the risk for coronary obstruction during valve deployment. In patients considered at high risk for coronary obstruction placing a coaxial guiding catheter extension such as the GuideLiner catheter (Cascular Solutions Inc., Minneapolis, MN, United States) in the coronary artery during valve deployment may allow emergent percutaneous coronary intervention.
Figure 3

Patient undergoing transfemoral transcatheter aortic valve implantation with a very low ostium of the right coronary artery. A: Patient with a very low ostium of the right coronary artery but potentially a large enough sinus valsalva for TAVI; B: Balloonvalvuloplasty with simultaneous injection of contrast media to estimate the risk for coronary obstruction; C: Successful implantation of an Evolut R. Supraannular injection shows a patent right coronary artery. TAVI: Transcatheter aortic valve implantation.

Patient undergoing transfemoral transcatheter aortic valve implantation with a very low ostium of the right coronary artery. A: Patient with a very low ostium of the right coronary artery but potentially a large enough sinus valsalva for TAVI; B: Balloonvalvuloplasty with simultaneous injection of contrast media to estimate the risk for coronary obstruction; C: Successful implantation of an Evolut R. Supraannular injection shows a patent right coronary artery. TAVI: Transcatheter aortic valve implantation. Choosing the ideal puncture site. Finally MSCT is routinely used to evaluate size, tortuosity and calcifications of the iliofemoral arteries and to determine the feasibility of transfemoral access[15]. MSCT provides detailed information about the height of the bifurcation of the common femoral artery in relationship to the femoral head. Furthermore, it allows visualization of the inferior epigastric artery which is located within the inguinal ligament. Finally, MSCT shows the extent of calcification at the level of the potential puncture site (Figure 4). Knowing your patients anatomy allows to perform a precise puncture under fluoroscopy guidance thus minimizing the risk for vascular injury[16,17].
Figure 4

Multislice computed tomography showing calcified right common femoral artery in a patient undergoing transfemoral transcatheter aortic valve implantation. A: Right common femoral artery with an arrow pointing at the ideal puncture site above the calcification; B: Right common femoral artery with an arrow pointing at the ideal puncture site above the height of bifurcation of the common femoral artery in relationship to the femoral head.

Multislice computed tomography showing calcified right common femoral artery in a patient undergoing transfemoral transcatheter aortic valve implantation. A: Right common femoral artery with an arrow pointing at the ideal puncture site above the calcification; B: Right common femoral artery with an arrow pointing at the ideal puncture site above the height of bifurcation of the common femoral artery in relationship to the femoral head. How to get involved in imaging, and why? Potential TAVI candidates are discussed by the interdisciplinary HeartTeam consisting of non-invasive cardiologists specialized in cardiac imaging, interventional cardiologists and cardiac surgeon to define the best treatment option for the individual patient. Evaluation of associated comorbidities that may limit the life expectancy or the recovery after the procedure is of particular importance. Results from pre-procedural invasive angiogram, echocardiogram and MSCT are reviewed for each patient. We would like to encourage all TAVI operators to review their patients MSCT again immediately before the procedure. Look at the iliofemoral access to choose the better side with less calcification or tortuosity, and choose the ideal puncture site. Then, perform a three dimensional multiplanar reconstruction of the annulus, measure the annular diameters, perimeter, and the area. Look for calcification at the level of the annulus, but also at the level of the LVOT. Finally, review the root and the coronary arteries. With routine, this can be performed in 2-3 min in most patients. There are two potential advantages of being able to analyze your patient’s images. First, you may improve your patient’s outcomes. Second, if you have a complication, you are more likely to understand it and learn from it. And this will again lead to better outcomes in the future.
  17 in total

Review 1.  Role of Cardiac CT Before Transcatheter Aortic Valve Implantation (TAVI).

Authors:  Mohamed Marwan; Stephan Achenbach
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

2.  A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.

Authors:  Yoshio Maeno; Yigal Abramowitz; Hiroyuki Kawamori; Yoshio Kazuno; Shunsuke Kubo; Nobuyuki Takahashi; Geeteshwar Mangat; Kazuaki Okuyama; Mohammad Kashif; Tarun Chakravarty; Mamoo Nakamura; Wen Cheng; John Friedman; Daniel Berman; Raj R Makkar; Hasan Jilaihawi
Journal:  JACC Cardiovasc Imaging       Date:  2017-04-12

Review 3.  Preprocedural CT evaluation of transcatheter aortic valve replacement: what the radiologist needs to know.

Authors:  Rodrigo A Salgado; Jonathon A Leipsic; Bharati Shivalkar; Lenz Ardies; Paul L Van Herck; Bart J Op de Beeck; Christiaan Vrints; Inez Rodrigus; Paul M Parizel; Johan Bosmans
Journal:  Radiographics       Date:  2014-10       Impact factor: 5.333

Review 4.  Practical considerations for optimizing cardiac computed tomography protocols for comprehensive acquisition prior to transcatheter aortic valve replacement.

Authors:  Omar K Khalique; Todd C Pulerwitz; Sandra S Halliburton; Susheel K Kodali; Rebecca T Hahn; Tamim M Nazif; Torsten P Vahl; Isaac George; Martin B Leon; Belinda D'Souza; Andrew J Einstein
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-07-05

5.  Annual Outcomes With Transcatheter Valve Therapy: From the STS/ACC TVT Registry.

Authors:  David R Holmes; Rick A Nishimura; Frederick L Grover; Ralph G Brindis; John D Carroll; Fred H Edwards; Eric D Peterson; John S Rumsfeld; David M Shahian; Vinod H Thourani; E Murat Tuzcu; Sreekanth Vemulapalli; Kathleen Hewitt; Joan Michaels; Susan Fitzgerald; Michael J Mack
Journal:  Ann Thorac Surg       Date:  2016-02       Impact factor: 4.330

6.  Anatomical and procedural features associated with aortic root rupture during balloon-expandable transcatheter aortic valve replacement.

Authors:  Marco Barbanti; Tae-Hyun Yang; Josep Rodès Cabau; Corrado Tamburino; David A Wood; Hasan Jilaihawi; Phillip Blanke; Raj R Makkar; Azeem Latib; Antonio Colombo; Giuseppe Tarantini; Rekha Raju; Ronald K Binder; Giang Nguyen; Melanie Freeman; Henrique B Ribeiro; Samir Kapadia; James Min; Gudrun Feuchtner; Ronen Gurtvich; Faisal Alqoofi; Marc Pelletier; Gian Paolo Ussia; Massimo Napodano; Fabio Sandoli de Brito; Susheel Kodali; Bjarne L Norgaard; Nicolaj C Hansson; Gregor Pache; Sergio J Canovas; Hongbin Zhang; Martin B Leon; John G Webb; Jonathon Leipsic
Journal:  Circulation       Date:  2013-06-07       Impact factor: 29.690

7.  Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure.

Authors:  Stefan Toggweiler; Ronen Gurvitch; Jonathon Leipsic; David A Wood; Alexander B Willson; Ronald K Binder; Anson Cheung; Jian Ye; John G Webb
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

8.  Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.

Authors:  Robert M A van der Boon; Bertrand Marcheix; Didier Tchetche; Alaide Chieffo; Nicolas M Van Mieghem; Nicolas Dumonteil; Olivier Vahdat; Francesco Maisano; Patrick W Serruys; A Pieter Kappetein; Jean Fajadet; Antonio Colombo; Didier Carrié; Ron T van Domburg; Peter P T de Jaegere
Journal:  Ann Thorac Surg       Date:  2013-11-19       Impact factor: 4.330

9.  Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.

Authors:  Peter Wenaweser; Stefan Stortecky; Dik Heg; David Tueller; Fabian Nietlispach; Volkmar Falk; Giovanni Pedrazzini; Raban Jeger; Oliver Reuthebuch; Thierry Carrel; Lorenz Räber; Franz W Amann; Enrico Ferrari; Stefan Toggweiler; Stephane Noble; Marco Roffi; Jürg Gruenenfelder; Peter Jüni; Stephan Windecker; Christoph Huber
Journal:  EuroIntervention       Date:  2014-12       Impact factor: 6.534

Review 10.  Patient selection for transcatheter aortic valve replacement: A combined clinical and multimodality imaging approach.

Authors:  Rosangela Cocchia; Antonello D'Andrea; Marianna Conte; Massimo Cavallaro; Lucia Riegler; Rodolfo Citro; Cesare Sirignano; Massimo Imbriaco; Maurizio Cappelli; Giovanni Gregorio; Raffaele Calabrò; Eduardo Bossone
Journal:  World J Cardiol       Date:  2017-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.